Latest Breaking News On - Subsequent therapy - Page 5 : comparemela.com

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited kingdomSan diegoKalvebod bryggeDavid freundelHematol hemoterAndrew carlsenJudith klimovskyOutcomes researchAbbvie biotechnology ltdCompany announcementNational comprehensive cancer networkData from the observational national lymphocare studyDiscovery researchAmerican society of hematology

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the

Eighteen total abstracts accepted for presentation and publication, including results from four clinical trials evaluating epcoritamab in multiple treatment settings and patient populationsOral presentations highlighting new findings from a clinical trial of epcoritamab in patients with relapsed/refractory (R/R) dif.

San diegoUnited statesNew jerseyUnited kingdomHematol hemoterDavid freundelAndrew carlsenJudith klimovskyExchange commissionLymphoma research foundationCompany announcementOutcomes researchNational comprehensive cancer networkAbbvie biotechnology ltdAmerican society of hematologyDiscovery research

Genmab and AbbVie Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

COPENHAGEN, Denmark (BUSINESS WIRE) Jun 27, 2023

United statesNew jerseyHematol hemoterMarisol peronGenmab us incLymphoma research foundationEuropean unionAbbvie biotechnology ltdDrug administrationCompany announcementEuropean medicines agencyData from the observational national lymphocare studyCorporate affairsMinistry of healthExchange commissionProject optimus

AbbVie and Genmab Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)

AbbVie and Genmab Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

United statesMariana cota stirnerHematol hemoterExchange commissionEuropean unionMinistry of healthLymphoma research foundationEuropean medicines agencyUs incData from the observational national lymphocare studyFollicular lymphomaSafety informationMarketing authorization applicationEuropean medicinesRelease syndromeFull prescribing information

AbbVie (ABBV) and Genmab (GMAB) Report Positive Topline Results from Phase 1/2 EPCORE NHL-1 Trial

AbbVie (ABBV) and Genmab (GMAB) Report Positive Topline Results from Phase 1/2 EPCORE NHL-1 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyKalvebod bryggeHematol hemoterAndrew carlsenMarisol peronEuropean unionCompany announcementExchange commissionDrug administrationCorporate affairsData from the observational national lymphocare studyGenmab us incAbbvie biotechnology ltdEuropean medicines agencyLymphoma research foundation